RESEARCH
Our most recent published research with the help of our volunteers.
White Paper
Chronic pain has been reported to affect over 25 million Americans with numerous underlining causes. Intravenous NAD+ therapy may provide relief from those suffering from chronic pain and neuropathy.
White Paper
As the United States is faced with drug overdose epidemic, NAD+ therapy offers a safe and effective tool to help those suffering from substance abuse disorder.
Press releases
Staying up to date with our recent discoveries and innovations.
CRABH Launch
New 501(c)(3) Organization Creates a Hub for Thought Leadership Around Addiction and Brain Research
Third Annual NAD Summit
Researchers and clinicians gather to discuss new discoveries in intravenous NAD+ therapy.
